Pharmacogenomics

Pharmacogenomics is also known as pharmacogenetics or drug-gene testing which is the study of how an individual’s genetic makeup affects their response to medications. This field aims to personalize drug therapy to optimize treatment outcomes and minimize adverse effects, ultimately enhancing the efficacy and safety of pharmaceuticals.

Key Objectives:
Personalized Medicine
Reducing Adverse Drug Reactions
Improving Healthcare Efficiency

    Related Conference of Pharmacogenomics

    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    March 09-10, 2026

    21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Singapore City, Singapore
    April 16-17, 2026

    19th World Congress on Stem Cell Research

    Tokyo, Japan
    April 23-24, 2026

    9th Annual Conference on Stem Cell and Regenerative Medicine

    Dubai, UAE
    May 04-05, 2026

    14th World Congress on Human Genetics and Genetic Diseases

    Paris, France
    May 25-26, 2026

    20th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    June 08-09, 2026

    9th Global Conference on Cell and Gene Therapy

    Rome, Italy
    June 15-16, 2026

    22nd Global Summit on Stem Cell & Regenerative Medicine

    Amsterdam, Netherlands
    June 15-16, 2026

    13th World Congress on Epigenetics and Chromosome

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in